Pfizer will spend $43 billion to buy Seagen and deepen its reach into treating cancer. Its key products use lab-made proteins that seek out cancer cells to help deliver a cancer-killing drug while sparing surrounding healthy tissue.
Pfizer buys Seagen for $43B, boosts access to cancer drugs. See story here.